Apr 26, 2018
F. Hoffmann-La Roche Announces First Quarter Sales 2018
Name of listed company: | Chugai Pharmaceutical Co., Ltd. |
Code number: | 4519 (1st Section of Tokyo Stock Exchange) |
Head office: | 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo |
President & CEO: | Tatsuro Kosaka |
Inquiries to: | Masahiko Uchida, |
General Manager, Corporate Communications Dept. | |
Tel:+81-(0)3-3273-0881 |
F. Hoffmann-La Roche Ltd. (hereafter “Roche”) [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today its First quarter sales 2018 (January 1 - March 31, 2018).
Roche owns 59.89% of Chugai's outstanding shares (61.29% of the total number of shares issued excluding treasury stock) as of end of March 2018.
The press release and presentation materials can be found on its website (https://www.roche.com).
Chugai’s performance for the period of January 1 to March 31, 2018 is included in the announced Roche Group’s results.
Media Releases | Investor Updates | Presentations |